✦ LIBER ✦

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

✍ Scribed by Morgan, R J; Doroshow, J H; Leong, L; Schriber, J; Shibata, S; Forman, S; Hamasaki, V; Margolin, K; Somlo, G; Alvarnas, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose doxorubicin, etoposide, and cy

✍ George Somlo; James H. Doroshow; Stephen J. Forman; Lucille A. Leong; Kim A. Mar 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 780 KB

Phase I/II study of tandem cycles of hig

✍ A. TIERSTEN; M. SELLECK; D.H. SMITH; I. WERTHEIM; E. KAUFMAN; D. HERSHMAN; L.T. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

A phase I–II study of high-dose melphala

✍ Weaver, C H; Greco, F A; Hainsworth, J D; Zhen, B; Baldwin, P; Wittlin, F; Lewis 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Phase II study of high-dose cyclophospha

✍ Klumpp, T R; Goldberg, S L; Magdalinski, A J; Mangan, K F 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

Pegase 03: a prospective randomized phas

✍ Biron, P; Durand, M; Roché, H; Delozier, T; Battista, C; Fargeot, P; Spaeth, D; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 190 KB